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PURPOSE. Like cancer cells, photoreceptor cells produce lactate aerobically, requiring lactate
dehydrogenase A (LDH-A). Cancer cells also use glycolytic intermediates for biosynthesis. The
molecular switch controlling glycolytic flow is thought to be an isoenzyme of pyruvate kinase
(PKM2). Here, we determined the expression and localization of PKM2 and LDH-A in
mammalian retina and make comparisons with the brain.
METHODS. Single- and double-labeling immunohistochemistry for PKM2, pyruvate kinase M1
(PKM1), and LDH-A were performed using retinal sections from C57BL/6 mice, Sprague-
Dawley rats, rabbits, marmosets, and humans. Pyruvate kinase M1 and PKM2 mRNA and
protein expression levels were quantified in rodent retina and brain by using qPCR and
immunoblotting. The quaternary forms of PKM2 in rat retina were also determined.
RESULTS. Pyruvate kinase M2 was present in some glial cells and rod and cone photoreceptors
in the retina of all species but was exclusively localized to glia in the brain. Pyruvate kinase
M1 was confined to neurons in the retina and brain. Lactate dehydrogenase A was principally
found in photoreceptors and inner portion of the avascular rabbit retina. Western blotting and
qPCR confirmed high levels of PKM2 and LDH-A in the retina. There was a 6- to 9-fold greater
expression of PKM2 mRNA in the rodent retina than in the brain. Both the dimeric (inactive,
biosynthesis-driving form) and the active tetrameric (glycolytic-driving) forms of PKM2 were
present in retina but not in brain.
CONCLUSIONS. Mammalian photoreceptors contain dimeric and tetrameric PKM2 and LDH-A.
This is consistent with the ability to switch between energy production and biosynthesis like
a proliferating tissue, possibly due to demands of opsin synthesis.
Keywords: lactate dehydrogenase, metabolism, optic nerve, PKM2, retina
Retinal photoreceptors have a metabolism that is in someways more reminiscent of a neoplastic cell than a central
nervous system neuron.1 That is, they face prodigious energy
demands to maintain their ‘‘dark current’’2 and large biosyn-
thesis requirements due to the rapid shedding and renewal of
their outer segments.3 Like cancer cells, photoreceptor cells
rely heavily on both glycolysis and oxidative phosphorylation to
meet energy demands, and like cancer cells, isolated retina has
a high glycolytic flux and lactate production even in the
presence of oxygen, a phenomenon known as aerobic
glycolysis or the Warburg effect.4,5 Limited evidence indicates
that the retinal Warburg effect is actually predominantly
localized to photoreceptors with minimal contribution from
the inner retina.4,6–8 Relatively high levels of lactate production
by retinal cells in the presence of oxygen define the presence of
the Warburg effect but are difficult to measure in vivo. It is also
difficult to define the specific cellular source of lactate
production. A surrogate marker in vivo, thus, is the presence
of lactate dehydrogenase (LDH), consisting of the subunits
LDH-A and LDH-B. The LDH-A isoform catalyzes the conversion
of pyruvate to lactate, reforming nicotinamide adenine
dinucleotide (NADþ) to support ongoing glycolysis. Lactate
dehydrogenase A is used as a cancer biomarker and is under
consideration as a therapeutic target for cancer.9 To our
knowledge, the cell-specific localization of LDH-A in the retina
has never been reported.
Glycolysis in cancer cells, in addition to providing energy, is
also able to provide anabolic building blocks for cellular
proliferation.10 The requirement of a proliferating cell for both
glycolysis-derived biosynthesis and adenosine triphosphate
(ATP) production in the presence of oxygen has been termed
a ‘‘metabolic budget system’’ (MBS).11 Pyruvate kinase (PK)
catalyzes the final step of glycolysis, converting phosphoenol-
pyruvate to pyruvate. The molecular switch responsible for the
MBS is an isoenzyme of PK known as PKM2.11 An alternative
isoform, PKM1, is found in nonproliferating tissue.12 Structur-
ally, both PKM1 and PKM2 exist as homotetramers, configura-
tions that favor glycolytic flux. Pyruvate kinase M2, however,
unlike PKM1, is under allosteric control by the upstream
glycolytic intermediate fructose-1,6-biphosphate12 and the
amino acid serine.13 Allosteric modulation causes the PKM2
tetramer to dissociate to a dimer. Dimeric PKM2 is much less
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efficient at converting phosphoenolpyruvate to pyruvate, and
its presence therefore slows the rate of glycolytic flux; the
resultant accumulation of upstream glycolytic intermediates
can then be used for anabolic reactions. The presence of a
dimeric form of PKM2 within a cell, therefore, implies a
reduced rate of glycolysis and an increased level of biosynthesis
derived from glycolytic intermediates. Recent data indicate that
rodent photoreceptors contain PKM2,14 and intriguingly, that
anti-PKM2 antibodies are present in the serum of individuals
with age-related macular degeneration.15
In order to advance our understanding of the unique
metabolism of the retina, a detailed characterization of the
levels of expression, cellular distribution, and species corre-
spondence among PKM1, PKM2, and LDH-A in the retina
versus that in brain is needed. In this study, we investigated
expression of PKM1, PKM2, and LDH-A in the retina, optic
nerve, and cerebral cortex of mouse, rat, rabbit, common
marmoset (Callithrix jacchus), and human.
MATERIALS AND METHODS
Animals and Tissue Processing
This study was approved by the SA Pathology/Central Heath
Network (CHN) Animal Ethics Committee (Adelaide, Australia)
and conformed to the Australian Code of Practice for the Care
and Use of Animals for Scientific Purposes, 2004, and with the
Association for Research in Vision and Ophthalmology
statement for the use of animals in vision and ophthalmic
research. Adult Sprague-Dawley rats (approximately 250 g) and
C57BL/6 mice were housed in a temperature- and humidity-
controlled room with a 12L:12D cycle (lights on 7 AM) and
were provided with food and water ad libitum. Light-adapted
rodents were killed by transcardial perfusion with physiolog-
ical saline under deep anesthesia between 2 and 9 PM. Both
eyes with optic nerves attached were enucleated immediately.
The brain was also taken when necessary. Rabbit eyes were
obtained locally and fixed within 30 minutes of the animal’s
death.
Human ocular tissue for analysis was obtained from the Eye
Bank of South Australia, Flinders Medical Centre (Adelaide,
Australia), following guidelines of the Southern Adelaide
Clinical Human Research Ethics Committee; all tissues had
been screened to ensure there was no underlying ocular
disease, and all were from Caucasian donors 50 to 65 years of
age. Following ethical approval from the SA Pathology/CHN
Animal Ethics Committee (Adelaide, Australia), we obtained
ocular tissue from three adult marmosets (Callithrix jacchus)
belonging to the colony housed at the Queen Elizabeth
Hospital (South Australia, Australia) that were being eutha-
nized. We are grateful to Toby Coates for participating in this
tissue-sharing initiative, which has obvious benefits from an
ethical perspective.
There was no consistent orientation of rodent, primate, or
human globes with regard to nasal-temporal or dorsal-ventral
quadrants of the retina analyzed. Sections were typically taken
at the level of the optic nerve head and, hence, consisted of at
least two quadrants. We cannot categorically rule out
expression differences between different regions of the retina
in any species; however, no such differences were apparent in
any of our examinations.
Globes and optic nerves that were subsequently used for
immunohistochemistry were fixed by immersion in Davidson’s
solution for 24 hours and then transferred to 70% ethanol until
processing. Davidson’s solution (2 parts formaldehyde [37%], 3
parts 100% ethanol, 1 part glacial acetic acid, and 3 parts
water) is the preferred fixative for whole eyes as it provides
optimal tissue morphology while avoiding retinal detachment.
Brains were immersion-fixed in 10% buffered formalin until
processing. Following fixation, the brain was positioned in a
Kopf rat brain blocker (Kopf Instruments, Tujunga, CA, USA),
and 2-mm coronal slices were taken starting from the dorsal
and proceeding to the caudal portion of the brain. Brain slices
along with the globe and optic pathway were then processed
for routine paraffin-embedded sectioning. Globes were embed-
ded sagittally and optic nerves longitudinally. In all cases, 4-lm
sections were cut.
Immunohistochemistry
Colorimetric immunohistochemistry was performed as previ-
ously described.16–18 Briefly, tissue sections were deparaffi-
nized, endogenous peroxidase activity was blocked, and high-
temperature antigen retrieval was performed. Subsequently,
sections were incubated in primary antibody (Supplementary
Table S1), followed by consecutive incubations with biotiny-
lated secondary antibody and streptavidin-peroxidase conju-
gate. Color development was achieved using NovaRed (Sao
Paolo, Brazil) substrate kit.
For double-labeling fluorescent immunohistochemistry,
visualization of one antigen was achieved using a 3-step
procedure (primary antibody, biotinylated secondary antibody,
streptavidin-conjugated AlexaFluor 488 or 594 [Thermo Fisher
Scientific, Waltham, MA, USA]), and the second antigen was
labeled by a 2-step procedure (primary antibody, secondary
antibody conjugated to AlexaFluor 488 or 594). Sections were
prepared as described above and then incubated overnight at
room temperature in the appropriate combination of primary
antibodies. On the following day, sections were incubated with
the appropriate biotinylated secondary antibody for the 3-step
procedure plus the correct secondary antibody conjugated to
AlexaFluor 488 or 594 for the 2-step procedure, followed by
streptavidin-conjugated AlexaFluor 488 or 594. Sections were
then mounted using antifade mounting medium and were
examined using confocal fluorescence microscopy.
Western Blotting
Western blotting was performed as previously described.17
Briefly, tissue extracts were sonicated in homogenization
buffer, diluted with an equal volume of sample buffer, and
boiled for 3 minutes. Electrophoresis was performed using 10%
denaturing polyacrylamide gels. After proteins were separated,
they were were transferred to polyvinylidene fluoride mem-
branes for immunoprobing. Membranes were incubated
consecutively with the appropriate primary antibody (Supple-
mentary Table S1), biotinylated secondary antibody, and
streptavidin-peroxidase conjugate. Color development was
achieved using 3-amino-9-ethylcarbazole. Detection of b-actin
or glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was
assessed in all samples as a positive gel-loading control.
Determination of oligomerization status for PK isoforms was
undertaken by chemically cross-linking individual monomeric
subunits in tissue homogenates as follows: Tissues were
solubilized by sonication in 100 mM sodium phosphate buffer,
pH 7.4, plus 150 mM NaCl, to a final concentration of 10 lg of
protein/lL; each sample was divided into 2 tubes containing a
equal volumes of the homogenate. The cross-linking agent
disuccinimidyl suberate (DSS) was added to one tube from
each sample to a final concentration of 1 mM. Addition of an
equal volume of vehicle to the second tube from each sample
served as the non–cross-linked control. All samples were
incubated at 378C for 1 hour, and then free DSS was quenched
by addition of 1/5 volume of 1 M Tris-HCl (pH 7.5). The
protease inhibitor phenyl methyl sulphonyl fluoride was added
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to a final concentration of 100 lM, and an equal total volume of
sample buffer (62.5 mM Tris-HCl, pH 7.4, containing 4%
sodium dodecyl sulfate [SDS], 10% glycerol, 10% b-mercapto-
ethanol, and 0.002% bromophenol blue) was added before all
samples were heated to 808C for 10 minutes. Proteins were
resolved on 6% SDS-PAGE gels, and Western blots for different
PK isoforms were prepared as described above.
Real-Time RT-PCR
Reverse transcription (RT) polymerase chain reaction (RT-PCR)
studies were carried out as described previously.19 Briefly,
entire retinas and optic nerves were dissected, total RNA was
isolated, and first-strand cDNA was synthesized from DNase-
treated RNA. Real-time PCR reactions were carried out in 96-
well optical reaction plates by using the cDNA equivalent of 20
ng of total RNA for each sample in a total volume of 20 lL
containing 13 SYBR Green PCR Master Mix (Bio-Rad, Glades-
ville, Australia) and forward and reverse primers. Thermal
cycling conditions were 958C for 3 min and 40 cycles of
amplification at 958C for 12 seconds, annealing temperature
(Supplementary Table S2) for 30 seconds and 728C for 30
seconds. After the final cycle of the PCR, primer specificity was
checked by the dissociation (melting) curve method. In
addition, specific amplification was confirmed by electropho-
resis of PCR products on 3% agarose gels. PCR assays were
performed using the IQ5 iCycler machine (Bio-Rad), and all
samples were run in duplicate. Threshold cycles were
calculated using IQ5 iCycler software (Bio-Rad). All values
were normalized using the endogenous reference gene
GAPDH, and results are means 6 standard error of the mean
(SEM). Primer pairs (Supplementary Table S2) were designed
from sequences contained in the GenBank database, using the
primer design software Primer 3 (Whitehead Institute for
Biomedical Research; http://bioinfo.ut.ee/primer3-0.4.0/
primer3/, in the public domain) and were selected to amplify
sequences that spanned at least 1 intron. Primer sequences
were analyzed for melting temperature (Tm) and secondary
structure and primer-dimer formation by using NetPrimer
analysis software (http://www.premierbiosoft.com/netprimer,
in the public domain; Premier Biosoft, Palo Alto, CA, USA) and
verified for their specificity to the target sequence. Results
showed that all mRNAs were amplified with high efficiency
and linearity during RT-PCR. Mean amplification efficiencies, as
determined by plotting cycle threshold as a function of initial
cDNA quantity, ranged from 1.9 to 2.0.
Antibody Characterization
Full details of all antisera and antibodies used are shown in
Supplementary Table S1. Validation of antibodies to PKM1,
PKM2, and LDH-A are detailed in Results. Validation of
antibodies to b-actin, GAPDH, calretinin, PKCa, and glutamine




Validation of Antibodies. All antibodies were validated
prior to use. Three commercial antibodies, raised against
peptides corresponding to the human PKM1 sequence
(Supplementary Table S1) clearly recognized a protein of the
expected size (~60 kDa) by Western blotting in mouse skeletal
muscle (positive control tissue), brain, retina, and optic nerve
but not in liver (negative control tissue). All antibodies
provided high signal-to-noise cell-specific immunolabeling in
mouse, monkey, and human tissue sections, including positive
labeling in extraocular muscle, whereas incubation with
preimmune serum alone elicited no labeling. The patterns of
immunolabeling of the three antibodies were almost indistin-
guishable (compare Figs. 1 and 2 for data generated using the
antibody from Cell Signaling [Cell Signaling Technology, Inc.,
Danvers, MA, USA] with data in Supplementary Fig. S1, which
features data produced by antibodies from Proteintech
[Proteintech Group, Inc., Chicago, IL, USA] and Novus [Novus
Biologicals, Littleton, CO, USA]). Thus, it could be concluded
that in mouse, marmoset, and human tissues, the data
generated were specific to PKM1. Of note, PKM1 antibodies
failed to elicit the expected band by Western blotting using rat
samples; moreover, no specific staining was detectable in rat
tissue sections (data not shown). The explanation for the lack
of reactivity of the PKM1 antibodies in rat tissue almost
certainly resides in the composition of the single exon that
differentiates the PKM1 from the PKM2 isoform. Human,
marmoset, and mouse display a high degree of similarity in this
exon, but the rat sequence is more divergent.
mRNA and Protein Expression and Immunolocaliza-
tion. Pyruvate kinase M1 was expressed in high amounts in
the brain and retina of mice and rats, with cycle thresholds
(CT) of 17 to 18 cycles, compared to approximately 16 cycles
for the housekeeping (and fellow glycolytic) gene GAPDH.
There was an approximately 2.5-fold greater expression of
FIGURE 1. Western blot analysis of PKM1 and PKM2 expression in
mouse tissues. (A) Skeletal muscle (sk mus), liver (liv), brain (br), and
retina (ret) tissue extracts were probed for actin, GAPDH, PKM1, and
PKM2. Note the absence of actin and PKM2 in skeletal muscle, the
absence of PKM1 and PKM2 in liver, and the low level of PKM2 in brain.
(B) Evaluation of PKM1 and PKM2 expression in retina (lanes 1–4) and
optic nerve (lanes 6–9) from tissue extracts obtained from four different
mice. Pyruvate kinase M1 and PKM2 are detectable in all samples but in
greater amounts in the retina. The dotted line indicates that the first
sample was not run in the adjacent lane. M, molecular weight markers.
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PKM1 mRNA in cerebral cortex than in retina when
normalized to GAPDH (Table 1). Consistent with this pattern,
PKM1 protein, as detected by Western blotting, was more
highly expressed in cortex than in retina (Fig. 1A). Analysis of
retina and optic nerve samples from four mice revealed similar
PKM1 expression in all samples (Fig. 1B).
By immunohistochemistry, PKM1 was principally localized
to the inner retina of the mouse, specifically to populations of
cells in the ganglion cell layer (GCL) and the inner part of the
inner nuclear layer (INL), together with dendritic connections
in the inner plexiform layer (IPL) (Fig. 2). In the outer retina,
PKM1 immunostaining was evident in the outer plexiform
FIGURE 2. Representative images of PKM1 immunolabeling in mouse tissues. In the retina, positive labeling for PKM1 is localized principally to the
inner retina, notably the IPL and populations of cells in the GCL and inner part of the INL (A, B). In the outer retina, PKM1 is restricted to putative
axons in the OPL (arrow) and to photoreceptor inner segments (A, C). Pyruvate kinase M1 is robustly associated with RGC axons in the nerve fiber
layer of the retina (D) and the optic nerve (E, F). Pyruvate kinase M1 is also expressed by extraocular muscle (G). In the brain, PKM1 is associated
with neurons in gray matter (H) and axon bundles in white matter (I). Scale bars: 50 lm (A), 25 lm (B–I). IS, inner segments; ON, optic nerve;
ONH, optic nerve head; ONL, outer nuclear layer; OS, outer segments.
TABLE 1. Levels of PKM1, PKM2, and LDH-A mRNAs in Retina and Cortex of Rats and Mice
Gene Tissue GAPDH CT Target Gene CT DCT* mRNA Level†
PKM1 mouse Retina 16.5 6 0.4 18.7 6 0.5 2.2 6 0.1 0.23 6 0.02
Cortex 16.4 6 0.1 17.2 6 0.2 0.9 6 0.1 0.57 6 0.04
PKM1 rat Retina 16.2 6 0.2 18.4 6 0.3 2.2 6 0.1 0.24 6 0.02
Cortex 17.4 6 0.4 18.2 6 0.5 0.8 6 0.1 0.57 6 0.04
PKM2 mouse Retina 16.5 6 0.4 17.2 6 0.5 0.7 6 0.1 0.64 6 0.02
Cortex 16.4 6 0.1 20.4 6 0.1 4.0 6 0.1 0.07 6 0.003
PKM2 rat Retina 16.2 6 0.2 17.3 6 0.2 1.1 6 0.1 0.48 6 0.03
Cortex 17.4 6 0.4 21.2 6 0.3 3.8 6 0.1 0.08 6 0.01
LDH-A mouse Retina 16.5 6 0.4 18.6 6 0.3 2.1 6 0.1 0.26 6 0.02
Cortex 16.4 6 0.1 19.8 6 0.1 3.4 6 0.1 0.10 6 0.003
LDH-A rat Retina 16.2 6 0.2 17.8 6 0.2 1.6 6 0.1 0.35 6 0.03
Cortex 17.4 6 0.4 20.3 6 0.6 2.9 6 0.2 0.15 6 0.01
CT, cycle threshold.
* DCT, target gene CT ¼ GAPDH CT.
† Target mRNA level was expressed relative to that of GAPDH, where n ¼ 6.
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layer (OPL), in a location consistent with horizontal cell
synapses, and in photoreceptor inner segments (Fig. 2).
Pyruvate kinase M1 was robustly associated with retinal
ganglion cell (RGC) axon bundles throughout the nerve fiber
layer of the retina and the optic nerve, but there was no
discernible expression of PKM1 by optic nerve glia (Fig. 2).
Double-labeling experiments revealed that PKM1 colocalized
with calretinin in the GCL and INL (Fig. 3). Calretinin-positive
neurons are reported to be subsets of both amacrine cells and
RGCs.20 Pyruvate kinase M1 expression by RGCs and their
FIGURE 3. Double labeling immunofluorescence of PKM1 and PKM2 in mouse retina. Pyruvate kinase M1 colocalizes with some calretinin-positive
neurons in the GCL and INL ([A–C] arrows). In contrast, PKM1 is not expressed by glutamine synthetase-positive Mu¨ller cells ([D–F] arrows).
Pyruvate kinase M2 colocalizes with the rhodopsin labeling of photoreceptors (G–I). Pyruvate kinase M2 also colocalizes with some PKCa-positive
bipolar cell bodies in the INL and their terminals adjacent to the GCL ([J–L] arrows). As with PKM1, there is no obvious association of PKM2 with
glutamine synthetase-positive Mu¨ller cells ([M–O] arrows). Scale bar: 25 lm.
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axons, as well as that of amacrine cells, was confirmed by
colocalization with b3-tubulin, Brn3a, and parvalbumin (data
not shown). Notably, PKM1 did not colocalize with glutamine
synthetase (Fig. 3) or S100 (data not shown), indicating a lack
of discernible expression by Mu¨ller cells and astrocytes. In the
mouse brain, PKM1 was localized to neurons in gray matter
and axon bundles in white matter (Fig. 2). As in the retina and
optic nerve, there was no observable expression of PKM1 by
glial cells (Fig. 2).
In marmosets and humans, Western blotting (Supplemen-
tary Fig. S2) and immunohistochemistry (Fig. 4) indicated
expression of PKM1 in retina, optic nerve, and brain. The
distribution of PKM1 was fundamentally analogous to that
observed in the rodent, with positive labeling evident in
neurons and their axons, but not in glia. It should be noted,
however, that in the marmoset and human retina, unlike the
rodent retina, PKM1 distribution was more widespread,
encompassing neurons in the inner and outer part of the INL
as well as photoreceptor somata and inner segments.
Pyruvate Kinase M1
Validation of Antibodies. Initial analysis of antibodies
from two different commercial sources demonstrated that,
although both of the antibodies detected a band of approxi-
mately the expected size of 60 kDa, the antibodies detected
distinct bands of slightly different apparent size (Supplemen-
tary Fig. S3). Hence the Novus antibody (Supplementary Table
S1) was not used in this study, but two antibodies from Cell
Signaling (Supplementary Table S1) were used for subsequent
experiments as they were generated using peptides specific for
the region of PKM2 divergent from PKM1, and specificity was
independently verified using short interfering RNA (siRNA)-
based knockdown of PKM2.21 Further analysis showed the two
Cell Signaling antibodies recognized a protein of the expected
size by Western blotting in testis (positive control tissue)
(Supplementary Fig. S4) and retina but not in liver or skeletal
muscle (negative control tissues). Both of the antibodies
provided high signal-to-noise, cell-specific immunolabeling in
mouse, rat, rabbit, monkey, and human tissue sections. Neither
of the antibodies elicited positive labeling in extraocular
FIGURE 4. Representative images of PKM1 and PKM2 immunolabeling in marmoset and human tissues. In the marmoset and human retina, PKM1 is
widely distributed, with positive labeling evident in the GCL (arrow), INL, and ONL, both plexiform layers, and nerve fiber layer (A, B). Pyruvate
kinase M1 labels axon bundles in marmoset and human optic nerve (E, F). In marmoset and human brain, PKM1 is associated with neurons in gray
matter (I, J) and axon bundles in white matter (M, N). In marmoset and human retina, PKM2 is restricted to photoreceptors (C, D), astrocytes
(black arrows), and Mu¨ller cells (white arrow). In marmoset and human optic nerve (G, H), gray matter (K, L), and white matter (O, P), PKM2 is
associated with astrocytes. Scale bars: 50 lm (A–H), 25 lm (I–P).
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muscle (negative control), and incubation with preimmune
serum alone also elicited no labeling. Patterns of immunolabel-
ing of the two antibodies were indistinguishable. Thus, it can
be concluded that, in all species, the data generated were
specific to PKM2 (Figs. 1, 4, 5, 6, 7, 8).
mRNA and protein expression and immunolocaliza-
tion. Relative to GAPDH expression, there was 6-fold greater
expression of PKM2 mRNA in rat retina and 9-fold greater
expression in mouse retina than that in cortex (Table 1). The
abundance of the PKM2 transcript in the retina was evident by
the low CT findings in both mouse and rat (CT ~ 17), less than
1 CT greater than GAPDH. Consistent with mRNA data, PKM2
protein, as detected by Western blotting, was highly expressed
in retinal samples and barely detectable in cortex (Figs. 1A,
5A). Analysis of retina and optic nerve samples from four rats
and mice revealed PKM2 expression in all samples but much
fainter bands in optic nerve samples (Figs. 1B, 5B).
Distribution of PKM2 in rodent retina contrasted markedly
with that of PKM1. In both rats (Fig. 5) and mice (Fig. 6),
robust labeling of PKM2 was evident in photoreceptor cell
bodies and their inner and outer segments. Double-labeling
experiments showed that PKM2 colocalized with rhodopsin
(Fig. 3). Pyruvate kinase M2 was also associated with a
population of cells in the outer part of the INL, in the
histoanatomical location of bipolar cells, together with
terminals in the IPL. Confirmation that these cells were bipolar
cells was achieved by successful colocalization of PKM2 with
the optic nerve bipolar cell marker PKCa (Fig. 3). Pyruvate
kinase M2 was not associated with RGC axons in the nerve
fiber layer of the retina nor in the optic nerve but was localized
to astrocytes. Analogous to PKM1, PKM2 did not colocalize
with glutamine synthetase (Fig. 3) or S100 (data not shown) in
the INL, indicating a lack of discernible expression by Mu¨ller
cells. Importantly, 5-fold dilution of the PKM2 antibody
eliminated all labeling, with the exception of that associated
with photoreceptors, suggesting that photoreceptors express
higher levels of PKM2 than other retinal cells (data not shown).
In the rodent brain, PKM2 was exclusively associated with
astrocytes, in both gray and white matter (Figs. 5, 6).
It has been suggested that PKM2 expression in the retina is
restricted to photoreceptors.14 To corroborate our finding of
PKM2 expression by nonrod photoreceptors, we analyzed 8-
week-old rd1 mice, which feature completely degenerated rod
photoreceptors but some residual M-, L-, and S-cone photore-
ceptors (Supplementary Fig. S5). First, we probed retinal
extracts from rd1 mice and age-matched C57BL/6 (wild-type)
mice for rhodopsin kinase, calretinin, PKM1, and PKM2 by
Western blotting. Compared with wild-type retinas, there was
an absence of rhodopsin kinase, as expected, and a lower but
still clearly detectable amount of PKM2 in rd1 retinas (Fig. 7A).
Subsequently, we performed immunohistochemistry using
tissue sections and showed, as expected, unambiguous PKM2
labeling of bipolar cells, astrocytes, and probably cones in both
rd1 and wild-type retinas (Figs. 7B, 7C). The rod-dominant
rodent retina, however, is not ideal for demonstrating that
cones express PKM2. Moreover, although residual cones are
present within the rd1 retina, they may well not be
metabolically normal. Thus, to firmly establish whether cones
express PKM2, we used primate retina (see below).
In marmosets and humans, Western blotting (Supplemen-
tary Fig. S2) and immunohistochemistry (Fig. 4) indicated
expression of PKM2 in retina, optic nerve, and brain.
Distribution of PKM2 was broadly similar to that observed in
rodent, with positive labeling in the retina associated with
photoreceptors and astrocytes and in the optic nerve and brain
exclusively with astrocytes. Nevertheless, some differences
were apparent with regard to retinal expression compared
with that in rodents: first, in the marmoset, PKM2 was not
FIGURE 5. Analysis of PKM2 expression in rats. (A) Western blot analysis of PKM2 expression in rat tissues. Skeletal muscle (sk mus), liver (liv),
brain (br), and retina (ret) tissue extracts probed for actin, GAPDH, and PKM2. Note the absence of actin and PKM2 in skeletal muscle, absence of
PKM2 in liver, and low level of PKM2 in brain. (B) Evaluation of PKM2 expression in retina (lanes 1–4) and optic nerve (lanes 6–9) tissue extracts
obtained from four different rats. Pyruvate kinase M2 is detectable in all samples but in greater amounts in the retina. (C–F) Representative images of
PKM2 immunolabeling in rat tissues. In the retina, positive labeling for PKM2 is localized to a population of cells in the outer part of the INL and to
photoreceptor cell bodies and their segments (C). In addition, PKM2 is associated with terminals in the IPL and to astrocytes (C). In the optic nerve,
PKM2 is localized to cells with the morphology of astrocytes (D). In the brain, PKM2 is associated with astrocytes in gray matter (E) and white
matter (F). Scale bars: 50 lm (A), 25 lm (B–D).
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expressed by neurons in the outer part of the INL, a finding
that might be expected given the presence of PKM1 in these
cells in the marmoset (Fig. 4); second, PKM2 was weakly but
unambiguously associated with Mu¨ller cells (Figs. 4, 7;
Supplementary Fig. S6). In order to shed light on PKM
isoenzyme expression in cones, we examined distributions of
PKM1 and PKM2 in the cone-rich parafovea of the marmoset.
Data showed robust expression of both PKM1 and PKM2 by
cone axons in Henle’s fiber layer by photoreceptor somata and
by cone inner segments, whereas double-labeling experiments
showed that both isoenzymes colocalized with the cone
marker peanut agglutinin (Figs. 7D–H).
Quaternary Forms of PKM2 in Retina. Structurally, both
PKM1 and PKM2 exist as homotetramers, configurations which
favor glycolytic flux. A major functional difference between
PKM1 and PKM2, however, is that the latter isoform harbors a
binding site for fructose-1,6-bisphosphate, which serves as an
allosteric modulator and causes the PKM2 tetramer to
dissociate to a dimer. Dimeric PKM2 is much less efficient at
converting phosphoenolpyruvate to pyruvate, and its presence
therefore slows the rate of glycolytic flux; the resultant
accumulation of upstream glycolytic intermediates are then
available for use in anabolic reactions. The presence of a
dimeric form of PKM2 within a cell, therefore, implies a
reduced rate of glycolysis and an increased level of biosynthesis
derived from glycolytic intermediates. With this in mind, we
analyzed the relative levels of quaternary forms of PKM2 in the
rat retina using a crosslinking protein-immunoblotting ap-
proach. This clearly resolved the monomeric protein at the
expected molecular weight (~60 kDa). In retinal samples
subjected to the cross-linking reaction, protein species were
also present at molecular masses which corresponded to both
dimeric (~120 kDa) and tetrameric (~240 kDa) forms (Fig. 8).
Lactate Dehydrogenase A
Validation of Antibodies. Two commercial antibodies,
raised against human LDH-A (Supplementary Table S1), clearly
recognized a protein of the expected size (~35 kDa) by
Western blotting in skeletal muscle and liver (positive control
tissues) as well as retina, optic nerve and brain. Both antibodies
provided high signal to noise, cell-specific immunolabeling in
mouse, rat, rabbit, monkey, and human tissue sections,
including staining of extraocular muscle (positive control),
while incubation with preimmune serum alone also elicited no
signal. The patterns of immunolabeling of the two antibodies
were alike. Thus, it can be concluded that in all species, the
data generated are specific to LDH-A (Figs. 9, 10, 11, 12;
Supplementary Fig. S7).
mRNA and Protein Expression and Immunolocaliza-
tion. Lactate dehydrogenase A was expressed in large amounts
in retina of mice and rats, with cycle thresholds of ~18 cycles.
There was an approximately 2.5-fold greater expression of
LDH-A mRNA in rat and mouse retinas than in cortex after
FIGURE 6. Representative images of PKM2 immunolabeling in mouse tissues. In the retina, positive labeling for PKM2 is localized to a population of
cells in the outer part of the INL and to photoreceptor cell bodies and their segments (A–C). In addition, PKM2 is associated with terminals in the
IPL (A, B) and to astrocytes ([A, B, D] arrows). Pyruvate kinase M2 is not associated with RGC axons in the nerve fiber layer of the retina or the
optic nerve (D–F) but is localized to cells with the morphology of astrocytes (D–F). Pyruvate kinase M2 is not expressed by extraocular muscle (G).
In the brain, PKM2 is associated with astrocytes in gray matter ([H] arrows) and white matter ([I] arrows). Scale bars: 50 lm (A), 25 lm (B–I).
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normalization by GAPDH (Table 1). Consistent with this
pattern, LDH-A protein, as detected by Western blotting, was
more highly expressed in retina than in cortex (Fig. 9). Analysis
of retina and optic nerve samples from four rats and mice
revealed LDH-A expression in all samples but much fainter
bands in the optic nerve samples (Fig. 9B; Supplementary Fig.
S7).
The distribution of LDH-A in rodent retina paralleled
that of PKM2 in many respects. Thus, in both rats (Fig. 10)
and mice (data not shown), robust labeling of LDH-A was
evident in photoreceptor cell bodies and their inner and
outer segments. Lactate dehydrogenase A was likewise
associated with bipolar cell bodies in the INL, together
with their terminals in the IPL (Figs. 10, 11A–C). Lactate
dehydrogenase A also did not colocalize with S100-positive
Mu¨ller cells (Figs. 11A–C). Double labeling of PKM2 and
LDH-A revealed the expected colocalization in photorecep-
tors and bipolar cells (Figs. 11G–I). Unlike PKM2, weak
LDH-A immunoreactivity was associated with some cells,
putatively amacrine cells, in the inner part of the INL.
FIGURE 7. Analysis of PKM2 expression in mice lacking photoreceptors and in parafovea of the marmoset. (A) Retinal extracts from 8-week-old
C57BL/6 (wild-type [wt]) and age-matched rd1 mice were probed for actin, rhodopsin kinase (rhod kin), calretinin (calret), PKM1, and PKM2 by
Western blotting. Note the absence of rhodopsin kinase and the relatively lower level of PKM2 in Rd1 retinas. (B, C) Representative images of PKM2
immunolabeling in mouse retinas from 8-week-old C57BL/6 wt and age-matched rd1 mice. Both retinas display identical patterns of
immunolabeling, except that rd1 mice lack a photoreceptor layer. (D, E) Representative images of PKM1 and PKM2 immunolabeling in the
marmoset parafovea. Positive labeling is associated with cone axons in Henle’s fiber layer (yellow arrows), photoreceptor somata in the outer
nuclear layer, and cone inner segments. Double labeling immunofluorescence showed that PKM2 colocalized with the cone marker peanut
agglutinin in inner segments ([D–H] white arrows). Scale bars: 25 lm. PNA, peanut agglutinin lectin.
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Moreover, unlike PKM2, LDH-A did not localize to retinal or
optic nerve astrocytes (Fig. 10). In the optic nerve, LDH-A
expression was low with minimal expression by glial cells
and indeterminate labeling of axons (Fig. 10).
In the marmoset retina (Fig. 12), LDH-A was very strongly
expressed by photoreceptor cell bodies and their segments.
Lactate dehydrogenase A labeling was also associated with a
population of cells in the central part of the INL. These cells
are not Mu¨ller cells as LDH-A failed to colocalize with CRALBP-
positive Mu¨ller cells. Finally, weak LDH-A immunoreactivity
was detectable in the GCL. In the optic nerve, LDH-A was not
associated with glial cells, but axon bundles were lightly
stained. The pattern of LDH-A immunolabeling in the human
retina and optic nerve was similar to that observed in the
marmoset, although the GCL and nerve fiber layer were more
robustly labeled (Fig. 12).
PKM1, PKM2, and LDH-A Expression in Avascular
Retina
As a final experiment, we investigated distribution patterns of
LDH-A, and PKM1 and -2 in rabbit. Unlike rodents or primates,
the rabbit has an avascular retina. Any differences between the
vascular and avascular retina will impart a valuable perspective
to the role of PKM and LDH-A in the retina. Data showed that
distribution patterns of PKM1 in the avascular rabbit retina was
analogous to those described in vascular retinas, namely
expression by inner retinal neurons, photoreceptors, and
axonal fibers in the optic nerve but negligible association with
retinal or optic nerve glia (Supplementary Fig. S8). The
distribution of PKM2 also displayed similarities in both
avascular and vascular tissues, namely expression by photore-
ceptors and retinal and optic nerve glia. Nevertheless, PKM2
appears to be somewhat more abundant in the inner retina,
notably Mu¨ller cell processes, of the rabbit and slightly less
abundant in the outer retina compared to vascular retinas
(Supplementary Fig. S8). The distribution of LDH-A showed the
most marked dissimilarity between vascular and avascular
retinas, being abundant in neurons and glia in the inner retina,
but seemingly lacking in rod photoreceptors (Supplementary
Fig. S8).
DISCUSSION
The current study has demonstrated that PKM2 is abundantly
expressed in the photoreceptors of mammalian species
including humans. Our findings complement those of Lindsay
et al.,14 who likewise showed expression of PKM2 by rodent
photoreceptors. The PKM2 and LDH-A expression profile of
photoreceptors is typical of proliferating normal and neoplas-
tic cells rather than terminally differentiated neurons. The
metabolic implication of this isoenzyme pattern is that the cell
has both large energy and biosynthesis demands that can only
be met by a high glycolytic rate even in the presence of
oxygen. To our knowledge, retinal photoreceptors are the only
nondividing adult cell type to display this pattern.
There are four known isoforms of PK in mammalian cells
encoded by two genes, PKLR and PKM. PKLR is expressed in
the liver and erythrocytes. The PKM isoforms PKM1 and PKM2
are alternative splice products of the PKM gene. Christofk et
al.22 reported that the switch from expression of physiological
PKM1 to PKM2 in cancer cells was responsible for the Warburg
effect. However, Bluemlein et al.23 undermined this conclusion
by using proteomics to definitively show that PKM2 was
present in tumors and normal control tissue. Subsequently, Luo
et al.24 combined these observations into a coherent explana-
tion by reporting that the Warburg effect in cancer (HeLa) cells
was mediated via PKM2 serving as a coactivator of hypoxia-
inducible factor-1a (HIF-1a). They showed that prolyl hydrox-
ylation of PKM2 promotes the interaction of PKM2 with HIF-
1a, thereby stabilizing HIF-1a binding to the hypoxia response
elements of target genes, including LDH-A. They suggested that
FIGURE 8. Relative levels of quaternary forms of PKM2 in rat retina,
determined by using a cross-linking protein-immunoblotting approach
(see Methods). Three individual retina homogenates were each split
into 2 equal parts; 1 part was treated with the cross-linking reagent DSS
(þ), while the other was treated with vehicle (). In vehicle-treated
samples, there was clear resolution of monomeric PKM2 at the
expected molecular weight (~60 kDa). In retinal samples subjected to
the cross-linking reaction, protein species were also present at
molecular masses that corresponded to both dimeric (~120 kDa)
and tetrameric (~240 kDa) forms of PKM2.
FIGURE 9. Western blot analysis of LDH-A expression in rat and mouse
tissues. (A) Skeletal muscle (sk mus), liver (liv), brain (br), and retina
(ret) tissue extracts probed for LDH-A. Note the lower level of LDH-A in
brain samples. (B) Evaluation of LDH-A expression in retina (lanes 1–4)
and optic nerve (lanes 6–9) tissue extracts obtained from 4 different
rats and 4 different mice. Lactate dehydrogenase A is detectable in all
samples but in much greater amounts in the retina.
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these molecules are not expressed together under physiolog-
ical conditions in most tissues but occur in cancers due to the
frequent presence of hypoxia and/or other HIF stabilization
factors. Recent studies have demonstrated that PKM2 has
nonmetabolic, epidermal growth factor–dependent actions
that can promote tumorigenesis and the Warburg effect in
certain cancer cell lines.25–27 Other factors, particularly the
oncogene c-Myc for which PKM2 can also serve as a
transcriptional coactivator, are also mediators of the Warburg
effect in some neoplastic cells. However, the emerging
evidence indicates that PKM2 is a master regulator of the
Warburg effect in cancer.28,29
With occasional exceptions,30,31 cancer research reports
are replete with references to PKM2 as ‘‘tumor specific’’ or as
representing the ‘‘oncofetal’’ form of PK, which is replaced by
PKM1 in adult tissue, despite the original report of PK
isoenzymes demonstrating PKM2 in normal adult tissues (the
retina was not studied),32 and the recent report by Bluemlein
et al.23 demonstrating PKM2 in normal adult control tissues.
Clearly, PKM2 is not tumor-specific. Recent strategies to target
PKM2 as a novel cancer therapy33 should proceed cautiously
and at least include ophthalmic assessment in phase I trials.34
Although the changing quaternary structure of PKM2
regulates the flow of glycolysis and is under allosteric control
by upstream glycolytic intermediates12 and serine,13 provided
the cell has pyruvate, the catalytic activity of PKM2 is
theoretically not a fundamental requirement for the Warburg
effect (the production of lactate under aerobic conditions).
Conversion of pyruvate to lactate in the cytosol rather than the
entry of pyruvate into mitochondria, despite the presence of
oxygen, is the fundamental requirement. Hence, biosynthesis
demands are a plausible explanation but not a logical necessity
for the existence of the Warburg effect. In fact, recent
mathematical modeling that accounts for space limitations
within the cell (and the large volume occupied by mitochon-
dria relative to glycolytic enzymes) finds that a high glycolytic
rate optimizes ATP production when glucose is abundant.35
This finding explains the presence of the Warburg effect with
glycolytic ATP production (and lactate production) in highly
active skeletal muscle (which does not contain PKM2) when
oxygen is not limiting.36 The factors forcing conversion of
pyruvate to lactate in this situation are not clear. Although
cellular biosynthesis and PKM2 are not fundamental require-
ments for the Warburg effect, the convergence of evidence
indicates that PKM2 has important roles in regulating the
Warburg effect in cells with large biosynthesis and energy
demands.
Pyruvate kinase M1 was confined to neurons and axons in
the retina and brain in a pattern consistent with nonproliferat-
ing cells with a predominantly aerobic metabolism. X-ray
crystallography has demonstrated that PKM1 exists as pairs of
active dimers37; however, the isoform is not under allosteric
control by glycolytic intermediates.12 In contrast, PKM2 is
believed to exist as an active tetrameric form and a relatively
inactive dimeric form, termed M2-PK.38 The presence of the
dimeric form of PKM2 within a cell implies a reduced rate of
glycolysis and an increased level of biosynthesis derived from
glycolytic intermediates. Antibodies to ‘‘tumor M2-PK’’ are
commercially available and are used in diagnostic testing of
cancer; however, to our knowledge, the specificity of this
antibody to the proposed dimeric form has not been validated.
In our hands, tumor M2-PK antibody yielded data that are
consistent with the antibody binding nonselectively to both
PKM1 and PKM2 (data not shown). With this in mind, we
investigated the quaternary forms of PKM2 in the rat retina
using a crosslinking protein-immunoblotting approach. Using
this methodology, we clearly demonstrated the dimeric form in
retina. Hence, it seems likely that PKM2 is under allosteric
control by fructose-1,6-biphosphate in the mammalian retina in
a similar manner to proliferating tissue.12
As well as photoreceptors, PKM2 also colocalized with
bipolar cells in the rodent retina and astrocytes in the retina,
optic nerve, and brain. Interestingly, we could not demonstrate
either PKM1 or PKM2 localization to retinal Mu¨ller cells in rats
or mice. Our data are consistent with those of recent findings
by Lindsay et al.,14 who observed the same phenomenon in
mice. In a comprehensive series of experiments they described
novel metabolic pathways between retinal neurons and Mu¨ller
FIGURE 10. Representative images of LDH-A immunolabeling in rat retina and optic nerve. In the retina (A–C), positive labeling for LDH-A is
localized to a population of cells, putatively bipolar cells, in the outer part of the INL together with terminals in the IPL. Lactate dehydrogenase A is
also strongly expressed by photoreceptor cell bodies and their segments. Finally, weaker LDH-A labeling is associated with some cells in the inner
part of the INL. Lactate dehydrogenase A is not localized to retinal astrocytes (A, B, D). In the optic nerve (D, E), LDH-A expression is low with
minimal expression by axons and glial cells. As expected, LDH-A is expressed by extraocular muscle (F). Scale bars: 50 lm (A, D), 25 lm (B, C).
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cells deficient in pyruvate kinase.14 However, our results show
that PKM2 is expressed by Mu¨ller cells in marmosets, albeit at a
considerably lower level than in photoreceptors, suggesting
species differences in Mu¨ller cell metabolism. An evolutionary
difference was also apparent with regard to bipolar cells:
PKM2 was present in rodent bipolar cells, but primate bipolar
cells expressed PKM1. The biosynthesis demands of the
bipolar cells are likely to be less than the photoreceptors,
and unlike astrocytes bipolar cells do not have the capacity to
proliferate. Accordingly, an explanation for why rodent bipolar
cells have a glycolytic enzyme pattern that is different to the
pattern found in brain neurons and inner retinal neurons
(amacrine cells, retinal ganglion cells) is not immediately
apparent.
A limitation of the current study is that we did not obtain
data at different times during the light/dark cycle. Hence, we
have a static picture of the isoenzyme pattern. It is possible
that this pattern or relative amounts of isoenzyme would
fluctuate with disc shedding rates.39 However, Lindsay et al.14
recently reported that the pattern of PKM2 expression in mice
was not affected by light; thus, it appears unlikely that a major
diurnal change exists.
Lactate dehydrogenase is a tetrameric enzyme comprising
two major subunits A and/or B, (encoded by the Ldh-A and
Ldh-B genes, respectively) resulting in five isoenzymes (A4,
A3B1, A2B2, A1B3, and B4) that catalyze the forward and
backward conversion of pyruvate to lactate. Lactate dehydro-
genase A (LDH-5, M-LDH, or A4) is the predominant form in
skeletal muscle. Lactate dehydrogenase B (LDH-1, H-LDH, or
B4) is found in heart muscle. Lactate dehydrogenase was one of
the first enzymes recognized to have different isoforms,40 and
since their discovery, they have been conceptualized as having
different physiological roles based on different enzyme
kinetics: LDH-A predominantly catalyzing pyruvate to lactate,
and critical for the Warburg effect, and LDH-B catalyzing the
reverse reaction and predominating in well-oxygenated tissues.
Lactate dehydrogenase enzyme kinetics have been widely
studied, but reports are inconsistent, and simplistic notions
that their kinetics affect physiological roles at equilibrium have
recently been challenged.41 However, under conditions of high
glycolytic flux, varying kinetics are likely to significantly affect
function,41 and it would appear that LDH-A is a sine qua non
for the Warburg effect.
In 1964, Graymore42 noted that the expression of the LDH-
A isoenzyme in the retina was reduced in rats with inherited
‘‘retinitis pigmentosa,’’ characterized pathologically by loss of
the photoreceptors. This observation was interpreted to imply
that the photoreceptors were principally responsible for the
retinal lactate production. This supported earlier evidence that
the photoreceptors were particularly susceptible to glycolytic
inhibition.8 Similarly, Acosta et al.43 demonstrated a high
expression of LDH-A in mouse retina, in contrast to the
minimal expression in brain. They noted that the high
expression rate was lost in rd1 mice after the onset of
photoreceptor degeneration.43 These observations were drawn
from immunoblots, and almost all metabolic evidence for the
FIGURE 11. Double labeling immunofluorescence of LDH-A in rat retina. Lactate dehydrogenase A is not associated with S100-positive Mu¨ller cells
([A–C] arrows). In contrast, LDH-A colocalizes with some PKCa-positive bipolar cell bodies in the INL and their terminals adjacent to the GCL ([D–
F] arrows). Expression of LDH-A overlaps considerably with that of PKM2, with colocalization in photoreceptors as well as in bipolar cell bodies
and their terminals ([G–I] arrows). Scale bars: 25 lm (A–F); 50 lm (G–I).
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Warburg effect in the retina comes from experiments on whole
retinas, with no discrimination between the different retinal
layers. Researchers have obtained some information about the
relative glycolytic versus oxidative phosphorylation contribu-
tion of the outer retina compared to the inner retina from
electrophysiological studies in the presence of retinal ischae-
mia,4,44,45 but an understanding of retinal metabolism remains
far from complete. Our results indeed confirm the hypothesis
that photoreceptors express high levels of LDH-A. This was
true for all species analyzed. Lactate dehydrogenase A,
however, was not restricted to photoreceptors. Other neuronal
classes, such as bipolar cells and, to a lesser degree, amacrine
cells were also LDH-A-positive in certain species. In contrast,
neither astrocytes nor Mu¨ller cells were associated with LDH-A
immunolabeling in any species, suggesting that neither of these
cell types produce significant quantities of lactate. Similarly in
the optic nerve, LDH-A was not expressed by astrocytes or
oligodendrocytes.
To impart perspective to our results, we explored the
distribution patterns of LDH-A and PKM1 and -2 in the rabbit.
Unlike rodents or primates, the rabbit has an avascular retina.
Moreover, glycogen storage is abundant in the inner layers of
the rabbit retina, and particularly concentrated in Mu¨ller cells,
but is very limited in the rat or mouse.46 Our results showed
some discrepancies between avascular and vascular retinas,
most notably concerning LDH-A, which was abundant in the
inner retina but sparse in rod photoreceptors of the rabbit,
results contradictory to those obtained in vascular retinas.
These data agree with those of Ames et al.,47 who investigated
the energy requirements of the rabbit retina and concluded
FIGURE 12. Representative images of LDH-A immunolabeling in marmoset and human retina and optic nerve. In marmoset retina, LDH-A is strongly
expressed by photoreceptor cell bodies and their segments (A, B). Lactate dehydrogenase A labeling is also associated with a population of cells in
the central part of the INL ([A, B] black arrows). These cells are not Mu¨ller cells as LDH-A fails to colocalize with CRALBP ([D–F] white arrows).
Weak LDH-A immunoreactivity was detectable in the GCL (A). In the optic nerve, LDH-A was not associated with glial cells, but axon bundles were
weakly positive (C). The pattern of LDH-A immunolabeling in the human retina and optic nerve was similar to that observed in the marmoset,
although the GCL and nerve fiber layer were more robustly labeled (G–I). Scale bars: 50 lm (A, C, G, I), 25 lm (B, D–F, H).
TABLE 2. Relative Levels of PKM1, PKM2, and LDH-A Immunolabeling in Different Cell Rodent and Primate Populations
Tissue
Rodent Primate
PKM1 PKM2 LDH-A PKM1 PKM2 LDH-A
Inner retinal neurons þþþ þ þ þþþ þþ þ
Photoreceptors þþ þþþ þþþ þþ þþþ þþþ
Retinal glia  þ /þ  þþ /þ
Brain neurons þþþ  ND þþþ  ND
Brain glia  þþ ND  þþ ND
ND, not determined.
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that the inner retina was supported almost entirely by
anaerobic glycolysis to lactate, whereas the outer retina was
normally supported by oxidative metabolism. Our results are
also consistent with those of Poitry-Yamate et al.,48 who
showed that in the avascular guinea pig retina, Mu¨ller cells
produce lactate that is released and metabolized by photore-
ceptors. Overall, then, it appears that in the avascular inner
retina, the abundant supply of glycogen is metabolized to
lactate via LDH-A, whereas the photoreceptors have minimal
LDH-A and therefore likely do not produce lactate themselves.
In contrast, in the vascular retina, photoreceptors have a high
glycolytic rate and produce large quantities of lactate,
presumably via their high level of LDH-A, whereas the inner
retina is largely oxidative.
In conclusion, we characterized the cell-specific localization
of PKM1, PKM2, and LDH-A in the retina of five mammalian
species. An overview of the relative levels of PKM1, PKM2, and
LDH-A immunolabeling in the different cell rodent and primate
populations is shown in Table 2. The most striking finding was
the consistently high expression of PKM2 in the photorecep-
tors across all species in a pattern similar to that reported in
neoplastic tissue. Gardner et al.49 recently showed the
importance of glycolysis in retinal protein synthesis and
uncovered an interaction between glycolysis and Akt/mTOR-
regulation of anabolic pathways. Although Lindsay et al.14
found no incorporation of radiolabelled glucose into serine in
murine retinal explants over a 6-hour period, we propose that
the prodigious biosynthesis requirements associated with in
vivo disc shedding and turnover of opsin underpin the
isoenzyme pattern we have observed. The cellular requirement
for both energy and biomass production would explain the
existence of the Warburg effect in the photoreceptors. Our
findings suggest that photoreceptor metabolism may use PKM2
as the ‘‘molecular switch’’ between energy production and
biomass production. The presence of PKM2 in rod photore-
ceptors of the avascular retina supports this hypothesis, but
the relative lack of LDH-A in the same cell type casts some
doubt on the universal requirement of aerobic glycolysis for
photoreceptor homeostasis.
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